CAPTRUST Financial Advisors’s Nuvation Bio NUVB Stock Holding History

CAPTRUST Financial Advisors’s Portfolio NUVB Stock Details NUVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$176K	Buy	30,928 +3,177	+11%	+$15.5K	﹤0.01%	2925
2026 Q1	$119K	Sell	27,751 -708	-2%	-$3.94K	﹤0.01%	2784
2025 Q4	$255K	Sell	28,459 -40	-0.1%	-$248	﹤0.01%	2365
2025 Q3	$105K	Buy	28,499 +12,300	+76%	+$33.5K	﹤0.01%	2504
2025 Q2	$31.6K	Buy	+16,199	New	+$33.7K	﹤0.01%	2460
2022 Q3	–	Sell	-263	Closed	-$1K	–	3351
2022 Q2	$1K	Sell	263 -45	-15%	-$196	﹤0.01%	4711
2022 Q1	$2K	Buy	+308	New	+$1.73K	﹤0.01%	4514
2021 Q3	–	Sell	-27	Closed	–	–	4721
2021 Q2	$0	Buy	+27	New	+$308	﹤0.01%	4612

Other funds holding NUVB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OFM

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DFO

Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

CAPTRUST Financial Advisors's NUVB Position: Q2 2026 in Review

CAPTRUST Financial Advisors increased its Nuvation Bio (NUVB) stake by 11% in Q2 2026, buying an estimated $15.5K and bringing the position to 30,928 shares worth $176K. The position accounts for ﹤0.01% of the portfolio, ranked #2925.

CAPTRUST Financial Advisors first reported a position in NUVB in Q2 2021 and has held it in 8 quarters since. The position peaked at $255K in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

CAPTRUST Financial Advisors held 30,928 shares of Nuvation Bio worth $176K as of Q2 2026.
CAPTRUST Financial Advisors bought 3,177 Nuvation Bio shares in Q2 2026, an estimated $15.5K.
Nuvation Bio made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #2925 holding.
CAPTRUST Financial Advisors first reported a position in Nuvation Bio in Q2 2021 and has held it in 8 quarters since.
CAPTRUST Financial Advisors's Nuvation Bio position peaked at $255K in Q4 2025.
244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.